Abstract
This study was undertaken to determine the feasibility of using ultrasonography for diagnosis of postpartum anoestrus followed by its effective management and treatment in crossbred (Holstein-Friesian X zebu) cows. A total of 57 crossbred lactating cows with unobserved oestrus for ≥60 days postpartum was examined by ultrasonography at Central Cattle Breeding and Dairy Farm (CCBDF), Savar, Dhaka. Cows were divided into silent oestrus and true anoestrus groups by ultrasonography. The pregnancy was diagnosed transrectally using ultrasonography 28 - 35 days after AI. Cows with silent oestrus were treated with Cloprostenol (500 μg) followed by AI or with 2 doses of Cloprostenol 10 days apart followed by AI at observed oestrus. The true anoestrus cows were supplied with anthelmintic and vitamin ADE injection with balanced nutrition, treated with Gonadorelin (500 μg) followed by AI or with Gonadorelin followed by injecting Cloprostenol at 7 days interval and AI at observed oestrus. All cows with silent oestrus and true anoestrus were divided into different body condition score (BCS), milk yield, age and parity groups to determine their influence on outcome of treatment. Out of 57 anoestrus cows examined, 56% were confirmed as silent oestrus and 44% were confirmed as true anoestrus. In silent oestrus, 71% cows showed cyclicity and 43% became pregnant after treatment with Cloprostenol and 78% cows showed cyclicity and 50% became pregnant after treatment with 2 doses of Cloprostenol 10 days interval (P>0.05). In true anoestrus group, 60% cows showed cyclicity and 40% became pregnant when balanced diet was supplemented. Around 78% cows showed cyclicity and 44% became pregnant after treatment with Gonadorelin and 91% cows showed cyclicity and 55% became pregnant when Gonadorelin was followed by Cloprostenol at 7 days interval (P>0.05). Significant (P<0.05) influence of parity was observed in post-treatment cyclicity in true anoestrus cows. The Bangladesh Veterinarian (2019) 36(1 - 2): 33-41
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.